Trial Profile
Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 02 Nov 2015 New trial record
- 25 Aug 2015 Results published online in Diabetic Medicine: a journal of the British Diabetic Association.